BACKGROUNDS
Drug-eluting stents (DES) with biodegradable polymers have been developed to address the risk of thrombosis associated with first-generation DES. We aimed to determine the efficacy and safety of biodegradable polymer biolimus-eluting stents (BES) versus durable polymer DES.
METHODS
Systematic database searches of MEDLINE (1950 to June 2013), EMBASE (1966 to June 2013), the Cochran...